DigestRedComo funciona
Red
/
Empresas
Ha
No verificado

Harmony Biosciences Holdings, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosSaludWeb y redes sociales

35 Comunicados de prensa

Ver todos los comunicados de prensa
23/04/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
16/04/2026
Eventos
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
14/04/2026
Mercado laboral
Biotecnología
Sanidad
Salud
Farmacéutica
Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
02/04/2026
Mercado laboral
Salud
Ciencia
Farmacéutica
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
31/03/2026
Eventos
Web y redes sociales
Biotecnología
Sanidad
Salud
Farmacéutica
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
04/03/2026
Eventos
Salud
Medicina - Varios
Sanidad
Farmacéutica
Biotecnología
Harmony Biosciences to Participate in Upcoming Investor Conferences
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
24/02/2026
Web y redes sociales
Telefonía
Mercado de valores
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Sanidad
Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
17/02/2026
Industria
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Familia
Infancia
Ir de compras
Medicina - Varios
Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX® (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
10/02/2026
Biotecnología
Farmacéutica
Salud
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
12/01/2026
Salud
Medicina - Varios
Sanidad
Farmacéutica
Biotecnología
Industria
Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0